Strain WD, Frenkel O, James MA, Leiter LA, Rasmussen S, Rothwell PM, Sejersten Ripa M, Truelsen TC, Husain M
Among these drivers, metabolic factors including obesity, insulin resistance, and dyslipidemia, play a key role by facilitating the sustained mobilization, trafficking, and homing of immune cells into target tissues 15,16
I had the privilege of making medications and design treatment plans and drug plans for so many individuals helping them in their health and wellness journey
Enhanced Absorption: GLP-2s improvement of nutrient absorption could theoretically enhance overall metabolic health alongside GLP-1s effects
Professor Muresanus research contributions include: Principal investigator for the CARS trial (Cerebrolysin and Recovery After Stroke), the largest randomized controlled trial examining functional outcomes Lead investigator for CAPTAIN trials evaluating Cerebrolysin in traumatic brain injury populations Extensive research on neurotrophic factor signaling and neuroprotective mechanisms Development of multimodal therapeutic strategies combining Cerebrolysin with rehabilitation Investigations of dose-response relationships and optimal treatment protocols across neurological conditions His work has been instrumental in advancing understanding of peptidergic neuroprotection, though clinical translation challenges remain a focus of ongoing investigation
